Last Updated on September 8, 2024 by The Health Master
USFDA inspection
Dr. Reddy’s Laboratories, a leading global pharmaceutical company, has successfully navigated a recent US Food and Drug Administration inspection (USFDA inspection) of its Active Pharmaceutical Ingredient (API) manufacturing facility in Srikakulam, Andhra Pradesh.
The USFDA, after a thorough review of the facility, has issued a Voluntary Action Indicated (VAI) classification.
This positive outcome signifies that while minor issues were identified, they were not severe enough to warrant regulatory action.
Key Points from the USFDA Inspection:
- Successful USFDA Inspection: Dr. Reddy’s Laboratories has received a favorable outcome from the USFDA inspection of its API manufacturing facility.
- VAI Classification: The USFDA has classified the inspection as Voluntary Action Indicated, indicating minor issues were identified but do not require regulatory action.
- Positive Outlook for Future: The positive outcome bodes well for Dr. Reddy’s Laboratories‘ continued operations and supply of essential medicines to the US market.
Background:
In June 2024, the USFDA inspection was conducted at the Srikakulam facility, resulting in four observations.
However, Dr. Reddy’s Laboratories has diligently addressed these concerns, leading to the positive outcome of the recent USFDA inspection.
This successful USFDA inspection is a significant milestone for Dr. Reddy’s Laboratories, reinforcing its commitment to quality and compliance with international regulatory standards.
The company remains focused on providing high-quality, affordable medicines to patients worldwide.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Over 340 Pharma Companies overdue for USFDA inspection in India and China
USFDA issues EIR for Marksans Pharma Goa facility
USFDA inspection with positive VAI to Strides Pharma at Chennai
USFDA grants VAI classification to Dr Reddy’s at Visakhapatnam
USFDA warns of Quality Issues with Chinese Plastic Syringe
Data integrity is the biggest issue in Pharma Industry: USFDA official
Govt issues new uniform code for marketing of Medical Devices
Over 340 Pharma Companies overdue for USFDA inspection in India and China
APTI demands reservation of all Pharma Jobs for Pharmacy Graduates
Pharma Breakthrough: India starts producing API Clavulanic Acid
IPC Alert: Adverse Drug Reaction linked to Metronidazole
Dr. TV Narayana has received a prestigious FIP Fellowship Award
Delhi High Court: Interim Relief to Pharma Industry on 156 Ban drugs
Govt to frame Disposal Policy for Expired Drugs
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
